CHRISTOPHER NORTON: Open Payments
NPI 1033560784 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 45 payments from 11 companies in 2025. Trend: 2023 $1,828 · 2024 $1,182 · 2025 $983
Food & beverage: $914Education: $69
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 11 | $308 |
| GENZYME CORPORATION | 7 | $189 |
| ABBVIE INC. | 12 | $151 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $66 |
| Lilly USA, LLC | 2 | $50 |
| LEO Pharma Inc. | 2 | $47 |
| Galderma Laboratories, L.P. | 2 | $45 |
| Amgen Inc. | 2 | $43 |
| UCB, Inc. | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: TREMFYA, DUPIXENT, SKYRIZI, ILUMYA, TALTZ, ADBRY, Otezla, Bimzelx.
Industry payments across CA — which companies pay providers there.
